U.S. Markets open in 1 hr 12 mins

Analysts bullish on Boston Scientific's plans for 75 new products by 2022

Allison DeAngelis
Analysts bullish on Boston Scientific's plans for 75 new products by 2022

Boston Scientific CEO Michael Mahoney laid out the long-term strategy for the company late last week, including a plan to launch 75 new cardiac valve, brain stimulation and other products by 2022.